Shares of South Korean automakers Hyundai Motor (OTC: HYMTF) and Kia Corp declined on Thursday following U.S. President Donald Trump’s announcement of a 15% tariff on imports from South Korea, including automobiles, under a new trade agreement.
Hyundai shares slipped 2%, while Kia shares fell 3.3% in Seoul trading. The move marks a significant change from the previous 25% tariff on South Korean auto imports imposed by Washington in April, aligning the rate with tariffs on Japanese vehicles.
Prior to April, most South Korean auto imports entered the U.S. duty-free under the Korea-U.S. Free Trade Agreement (KORUS FTA), while Japanese vehicles faced a 2.5% tariff. The new deal removes the competitive tariff advantage South Korean automakers previously held over Japanese rivals, potentially impacting Hyundai and Kia’s pricing power in the U.S. market.
Analysts say the revised tariff rate could narrow the gap in competitiveness between South Korean and Japanese automakers in North America, where both Hyundai and Kia have seen strong demand for electric vehicles and SUVs. The companies may need to reassess pricing and production strategies to maintain market share amid evolving trade dynamics.
The U.S.-South Korea trade agreement comes amid broader efforts by Washington to restructure tariffs and strengthen domestic manufacturing. Industry watchers expect further negotiations between the two countries as both seek to balance trade relations and protect key automotive sectors.
The announcement underscores growing geopolitical and trade tensions impacting the global auto market, with investors closely monitoring potential ripple effects on supply chains and export strategies for major automakers.


Samsung Shares Surge After Strike Deal Eases Labor Tensions
Dollar Eases as US-Iran Peace Deal Report Impacts Forex and Bond Markets
Japan Manufacturing Growth Slows in May as Services Sector Stagnates Amid Rising Middle East Supply Costs
Iran-U.S. Talks Continue as Strait of Hormuz and Uranium Dispute Stall Peace Efforts
TrumpRx Expands Discount Drug Access With 600 Generic Medications
Blackstone and Google Launch AI Cloud Venture, Pressuring CoreWeave and Nebius Shares
Australia Regulator Flags Private Credit Risks Amid Global Market Uncertainty
NHS shakeup: if it sounds like we’ve been here before, it’s because we have
SpaceX IPO Nears as Goldman Sachs Set to Lead Historic $75 Billion Offering
Trump Signals Tough Stance on Iran Uranium Stockpile as Nuclear Talks Show Limited Progress
X Corp Loses Legal Battle Over Australia Child Safety Fine
Texas Sues Meta Over WhatsApp Encryption Claims
Oil Tankers Exit Strait of Hormuz as Trump Signals Possible Iran Deal
SoftBank Shares Surge as OpenAI IPO Buzz and SB Energy Filing Boost AI Optimism
Oil Prices Climb as Trump Warns of Possible U.S. Strike on Iran
Takeda Hit With $885M Verdict Over Amitiza Generic Drug Delay Scheme 



